Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer
Subir Biswas, Gunjan Mandal, Sougata Roy Chowdhury, et al.
The Journal of Immunology (2019) Vol. 203, Iss. 12, pp. 3447-3460
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Isolation and characterization of exosomes for cancer research
Le Zhu, Haoting Sun, Shun Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 363
Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes
Maedeh Arabpour, Amene Saghazadeh, Nima Rezaei
International Immunopharmacology (2021) Vol. 97, pp. 107823-107823
Closed Access | Times Cited: 302
Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
Zhengjun Lin, Yanlin Wu, Yiting Xu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 182
On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
Adilson Fonseca Teixeira, Peter ten Dijke, Hong‐Jian Zhu
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 165
Stromal cells in the tumor microenvironment: accomplices of tumor progression?
Yan Zhao, Meili Shen, Liangqiang Wu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 161
Exosomes and breast cancer drug resistance
Xingli Dong, Xupeng Bai, Jie Ni, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 150
Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update
Luise Müller, Antje Tunger, Manja Wobus, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 129
Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles
Jing Wang, Motao Zhu, Guangjun Nie
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113974-113974
Closed Access | Times Cited: 120
C1q+ macrophages: passengers or drivers of cancer progression
Margot Revel, Catherine Sautès‐Fridman, Wolf H. Fridman, et al.
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 517-526
Open Access | Times Cited: 105
Exosomes and exosomal RNAs in breast cancer: A status update
S. Ayshwarya Lakshmi, Thomas A. Hughes, Sulochana Priya
European Journal of Cancer (2020) Vol. 144, pp. 252-268
Closed Access | Times Cited: 124
Small extracellular vesicles in cancer
Komal Abhange, Amy Makler, Yi Wen, et al.
Bioactive Materials (2021) Vol. 6, Iss. 11, pp. 3705-3743
Open Access | Times Cited: 104
Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions
Kerri Wolf-Dennen, Nancy Gordon, Eugenie S. Kleinerman
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 98
Mesenchymal Stem Cell-Macrophage Crosstalk and Maintenance of Inflammatory Microenvironment Homeostasis
Di Lu, Yan Xu, Qiuli Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 98
TNF-α and IFN-γ Participate in Improving the Immunoregulatory Capacity of Mesenchymal Stem/Stromal Cells: Importance of Cell–Cell Contact and Extracellular Vesicles
Lucero López-García, Marta Elena Castro-Manrreza
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9531-9531
Open Access | Times Cited: 96
Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy
Fusheng Zhang, J.J. Guo, Zhenghou Zhang, et al.
Cancer Letters (2021) Vol. 526, pp. 29-40
Open Access | Times Cited: 96
Immunosuppressive Effects of Mesenchymal Stem Cells-derived Exosomes
Xiaoli Qian, Nan An, Yifan Ren, et al.
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 2, pp. 411-427
Closed Access | Times Cited: 91
Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization
Jiangmei Wang, Jie Xia, Ruoqiong Huang, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 90
Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
Tianhang Li, Tianyao Liu, Wenjie Zhu, et al.
Clinical Medicine Insights Oncology (2021) Vol. 15
Open Access | Times Cited: 69
Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment
Len Frisbie, Ronald J. Buckanovich, Lan Coffman
Stem Cells (2022) Vol. 40, Iss. 8, pp. 705-715
Open Access | Times Cited: 69
Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity
Rui Zhang, Juchuanli Tu, Suling Liu
Seminars in Cancer Biology (2021) Vol. 82, pp. 11-25
Open Access | Times Cited: 62
Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers
Tianhan Xu, Sihui Yu, Jiawen Zhang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 60
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition
Sandra Cascio, Chelsea Chandler, Linan Zhang, et al.
Science Advances (2021) Vol. 7, Iss. 46
Open Access | Times Cited: 60
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment
Xiwei Wang, Yanmei Zhang, Xiaofeng Mu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 2, pp. e003832-e003832
Open Access | Times Cited: 46
Recent advances in exosome-based immunotherapy applied to cancer
Jindong Xie, Zihan Zheng, Ling Tuo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top